ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹143 Cr | ₹466 Cr | ₹757 Cr | ₹67 Cr | ₹33 Cr |
What is the latest Total Non-Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹143 Cr |
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹757 Cr |
| Mar2023 | ₹67 Cr |
| Mar2022 | ₹33 Cr |
How is Total Non-Current Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹143 Cr | -69.37 | |
| Mar2025 | ₹466 Cr | -38.43 | |
| Mar2024 | ₹757 Cr | 1,023.14 | |
| Mar2023 | ₹67 Cr | 106.11 | |
| Mar2022 | ₹33 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹16,724.1 Cr | 3.1% | 17.3% | 40.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | 3.1% |
17.3% |
40.9% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses